News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
174 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28549)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (3178)
November (247)
Day
1 (167)
2 (22)
3 (10)
4 (48)
5 (185)
6 (145)
7 (156)
8 (155)
9 (41)
12 (152)
13 (137)
14 (135)
15 (192)
16 (43)
18 (37)
19 (172)
20 (163)
21 (127)
22 (143)
23 (101)
25 (36)
26 (231)
27 (174)
28 (122)
29 (195)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
4
5
6
7
8
9
12
13
14
15
16
18
19
20
21
22
23
25
26
27
28
29
30
Press Releases
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
October 27, 2026
·
1 min read
Earnings
Novartis faces $1.9B hit from Avidity fail but maintains confidence in $12B buy
Novartis remains “very happy” with its $12 billion acquisition of Avidity Biosciences, despite a Phase 3 disappointment for the antibody-oligonucleotide conjugate del-desiran.
October 27, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131
October 27, 2026
·
7 min read
Press Releases
Mammogen and MammoLink Partner to Advance a New Model for Community-Based Breast Cancer Detection
October 27, 2026
·
4 min read
Press Releases
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
October 27, 2026
·
9 min read
Press Releases
Fortrea to Participate in Jefferies Global Healthcare Conference 2026
October 27, 2026
·
1 min read
Press Releases
Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
October 27, 2026
·
4 min read
Press Releases
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
October 27, 2026
·
1 min read
Press Releases
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
October 27, 2026
·
3 min read
Press Releases
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET
October 27, 2026
·
3 min read
Previous
4 of 18
Next
